OAM
ABEO icon

Oxford Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Oxford Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,121
Closed -$118K – 467
2024
Q4 		$118K Buy
+21,121
New +$130K 0.05% 382
2024
Q3 		– Sell
-19,059
Closed -$80.8K – 299
2024
Q2 		$80.8K Buy
+19,059
New +$97.2K 0.08% 252
2020
Q1 		– Sell
-4,888
Closed -$400K – 210
2019
Q4 		$400K Buy
+4,888
New +$345K 0.01% 1332

Other funds holding ABEO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Oxford Asset Management's ABEO Position: Q1 2025 in Review

Oxford Asset Management sold out of Abeona Therapeutics (ABEO) in Q1 2025, closing a stake of 21,121 shares — an estimated $118K sold.

Oxford Asset Management first reported a position in ABEO in Q4 2019 and held it in 3 quarters. The position peaked at $400K in Q4 2019. 71 funds tracked by Wall St. Rank hold ABEO as of Q1 2025.

  • Oxford Asset Management reported no remaining Abeona Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Oxford Asset Management sold 21,121 Abeona Therapeutics shares in Q1 2025, an estimated $118K.
  • Oxford Asset Management first reported a position in Abeona Therapeutics in Q4 2019 and held it in 3 quarters.
  • Oxford Asset Management's Abeona Therapeutics position peaked at $400K in Q4 2019.
  • 71 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2025.

Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.